Massimo Levrero MD

Massimo Levrero is a Professor of Medicine at the University Claude Bernard Lyon 1 (UCLB1), Lyon, France, and Praticien Hospitalier in the Service d’Hepatologie et Gastroenterologie - Hospital de la Croix Rousse - Hospices Civils de Lyon. He is Deputy Director of the Institute of Hepatology of Lyon (IHU-Lyon), France he leads a Research Unit on ”Epigenetics and Epigenomics of Hepatocellular Carcinoma”, at the Centre de Recherche en Cancérologie de Lyon (CRCL) – INSERM U1052. He also serves as an Associate Member at the IIT - Sapienza Center for Life NanoScience (CLNS) in Rome and he is on leave of absence from the Department of Internal Medicine (DMISM) at the Sapienza University of Rome, where he had his research activity and academic practice in hepatology until 2014.

Professor Levrero trained and completed his residency at Sapienza before holding posts at the University Paris VI and the Institut Gustave Roussy in Paris. He has acted as Scientific Secretary of EASL (European Association for the Study of the Liver) and he currently presides over the CSS12 study session on basic and translational research on viral hepatitis at the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). He is a founding member and sits on the Governing Board of ICE (International Coalition to Eliminate HBV).

He is actively involved in clinical research and treatment of HBV and HCV chronic hepatitis and he served as Network Coordinator and/or Primary Investigator in a number of research projects and clinical studies. HBV research focuses on the epigenetic regulation of cDNA function and HBV replication, the identification of new targets for anti-viral therapy, and liver oncogenesis in HBV-related hepatocellular carcinoma. Additional research interests include signal transduction and transcription in the liver; IFN transcriptome; and chromatin modifiers in solid tumor development and progression.